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 Abstract:  
Objective: Thyroid status can profoundly influence kidney function and also impact 
vascular endothelial function. This can be of substantial importance for the general 
population, but particularly for patients with diabetes who are predisposed to develop 
generalized vascular impairment due to multi-factorial causes leading to microalbuminuria, 
chronic kidney disease and overt nephropathy. The purpose of this study was to determine the 
relationship between serum thyrotropin (TSH) and urine albumin excretion in patients with 
diabetes.  
Methods:   A total of 433 patients were included in his retrospective cross sectional study. 
Data included anthropometric measurements and  estimation of HbA1c, lipid profile, renal 
function (creatinine and eGFR), free thyroxine (FT4), thyroid stimulating hormone (TSH) 
and a spot urine sample for urine albumin creatinine ratio (UACR). Males with UACR > 2.5 
and females > 3.5 mg/mmol were considered to have microalbuminuria.  
Results: 34.9% patients had microalbuminuria,. The prevalence for microalbuminuria 
increased according to TSH quartiles [26.9, 34.6, 38.5 and 44.9%, P for trend =0.02]. In a 
fully adjusted logistic regression model higher TSH levels were associated with high 
prevalence of microalbuminuria [adjusted odds ratio 2.06 (95% CI 1.14-3.72); p=0.02)] while 
comparing the highest with the lowest quartile of TSH. Multiple linear regression analysis 
showed that serum TSH level was independently associated with UACR (β = 0.007, t = 2.03 
and p = 0.04). We also established that the risk for having microalbuminuria was higher with 
rise in TSH concentration in patients with younger age (<65 years), raised BMI (≥25 kg/m
2
), 
hypertension, type 2 diabetes and hyperlipidemia and age was the most important 
determinant (P for interaction = 0.02).  
Conclusion: Serum TSH even in the euthyroid range was positively associated with 
microalbuminuria in euthyroid patients with diabetes independent of traditional risk factors. 
This suggests TSH may have a key role in the pathogenesis of microalbuminuria in high risk 
patients.     
 
 
 
 
 
 
 Introduction  
Thyroid hormones are essential for the embryonic development of kidneys. Furthermore they  
regulate several physiological functions of the kidney in the adult life both directly and 
indirectly. The direct effects are usually on the glomerular function, the tubular absorptive 
and secretory capacities and the functioning of different electrolyte pumps whereas indirect 
actions are due to its influence on the cardiovascular system which eventually affects the 
renal blood flow (RBF).
 1
 On the other hand, the kidney also exhibits substantial influence on 
the synthesis, secretion, metabolism and elimination of thyroid hormones and is a target 
organ of some iodothyronines action. 
2,3
 Such a dynamic interplay can alter significantly in a 
dysthyroid state (hypo or hyperthyroidism) leading to changes in clinical renal parameters 
like glomerular filtration rate (GFR), urine specific gravity (USG), urinary protein creatinine 
ratio (UPCR) and markers of tubular function 
4
 Likewise, moderate to advanced renal disease 
can lead to thyroid hormone dysfunction due to alteration in renal haemodynamics and 
manifest as subclinical or overt thyroid disease. 
5
 
Microalbuminuria is major marker of endothelial damage and an important determinant of 
vascular disease especially in diabetic patients. Moreover it increases the risk of diabetes, 
hypertension, decline in renal function and cardiovascular (CV) and all cause mortality in non 
diabetic subjects. Thyroid hormones have been also crucially linked to endothelial damage 
due to its influence on dilatation of blood vessels, production of vasodilator molecules, 
inhibition of angiotensin II receptor and effects on signal processes that regulate endothelial 
function and homeostasis. 
6,7
 As thyroid function and microalbuminuria are both associated 
with endothelial damage and vascular disease, several authors have studied this inter-
relationship intricately. Albuminuria has been identified to be an independent risk factor for 
elevated levels of thyroxine (T4) in patients with chronic kidney disease (CKD). 
8
 Free 
triiodothyronine (FT3) concentrations were found to be independently associated with 
microalbuminuria in a euthyroid cohort 
9
 and also in patients with diabetic nephropathy who 
were euthyroid as well. 
10
 Others have also established that subclinical hypothyroid disease is 
independently associated with microalbuminuria in pre-diabetic adults 
11
 and in patients with 
type 2 diabetes. 
12
 
In diabetic patients, albuminuria remains a well established micro vascular complication and 
can lead to progressive renal impairment and atherosclerotic vascular disease. Serum 
thyrotropin (TSH) has been established to be independently associated with renal function 
and CKD in normoglycaemic euthyroid adults 
13
 which is expected to worsen in overt or 
subclinical thyroid disease. The evidence regarding the association of urine albumin excretion 
and serum TSH in euthyroid diabetic adults is scarce. In this study we aimed to investigate 
this relationship in a large Caucasian adult population.          
Patients and Methods  
Study population and Design  
This is a retrospective cross sectional analysis of patients who attended the diabetes clinic at 
our hospital from October 2010 to May 2015. A total of 598 patients were included initially 
but upon exclusion only 433 were found to be eligible for the study. Patient’s were included 
if they had anthropometric indices, bloods [renal function, HbA1c, lipid profile, thyroid 
function] and a spot urine sample for albumin creatinine ratio (UCAR) checked during their 
attendance. Patients were excluded if they had biochemical evidence of thyroid disease 
and/or receiving thyroxine, carbimazole, propylthiouracil, lithium, glucocorticoids, 
amiodarone, antipsychotic and antiepileptic drugs [n=36]. We also excluded patients who had 
established kidney disease [n=68] or were taking medications like Angiotensin converting 
enzyme (ACE) inhibitors/Angiotensin receptor blockers (ARB) [n=61]. Anthropometric 
parameters like weight, height and blood pressure were measured by nurses in the outpatient 
department. Body mass index was calculated using the formula: weight in Kg/height in m
2
. 
Patients were defined to have hypertension if their systolic blood pressure (SBP) was > 140 
mmHg and/or diastolic blood pressure (DBP) was > 90 mmHg [average of three 
measurements] or when they had an established diagnosis of hypertension and were taking 
regular medications. Patients were defined to have hyperlipidemia according to National 
Cholesterol Education Program Adults Treatment Panel III (NCEP ATP III) criteria. 
14
 A first 
voided early morning spot urine sample was collected for assessing UCAR as containers are 
sent routinely to patients prior to their visit to the clinic. Patients were defined to have 
microalbuminuria if their UACR was > 2.5 mg/mmol in males and > 3.5 mg/mmol in 
females. The study was registered and approved by the Research and Development 
department of Cwm Taf University Health Board with the project number CT/580/15. All 
data were handled according to Caldicott principles.	 
 
 Biochemical measurements  
(TBC)  
 
 
Data Analysis  
Continuous variables are presented as means ± standard deviation (SD) where possible   and 
as medians and interquartile range (IQR) if not approximating the normal distibution .  We 
used paired “t” test to compare means between subgroups and Mann Whitney test to 
compare medians.  
The study population were divided into four groups according to the quartiles of TSH. We 
described demographic and metabolic and demographic features in each quartile and a P for 
trend was calculated across TSH quartiles.  
We investigated the association of TSH categories and microalbuminuria by using 
univariable and multivariable adjusted logistic regression models using UACR as the 
dependent variable and TSH categories as the independent variable. In multivariate logistic 
regression model we adjusted for potential confounding factors like age, sex, BMI, type of 
diabetes, SBP, FT4 and high lipids. We also confirmed the findings of logistic regression 
models by performing additional bootstrap analysis.  
We also studied if the association of serum TSH and microalbuminuria was more prominent 
in certain subgroups by performing stratified analyses on the association between TSH and 
the risk of microalbuminuria by the prominent risk factors like gender, age, BMI, 
hypertension, eGFR and hyperlipidemia. Adjusted odds ratio was calculated for increase of 
each 1 SD in log TSH concentration in subgroups of different variables. A P value for 
interaction was calculated using likelihood ratio tests in each subgroup to evaluate their 
impact on the association of serum log TSH and microalbuminuria risk.  For all statistical 
analysis a P value of < 0.05 was considered to be statistically significant. All statistical 
analysis was undertaken using	STATA	version	12	(STATACORP,	College	Station,	TX,	USA).	 
 
 Results  
1. Characteristics of the study population  
Table 1 shows the baseline characteristics of the study population which had a mean age of 
60 ± 15.5 years and majority of them were males [273/433 (63.1%). Most of our patients had 
Type 2 diabetes [379/433 (87.5%)] and the overall glycaemic control for the whole group 
was sub-optimal [HbA1c – 8.8 ± 1.9%]. In the total group the prevalence of 
microalbuminuria was 34.9% and majority of patients were males 69.5% (UACR > 2.5 
mg/mmol) in comparison to females 30.5% (UACR > 3.5 mg/mmol).  
Table 2 demonstrates the general characteristics and metabolic parameters of the study 
population when they were divided into four groups according to quartiles of TSH with the 
first quartile representing the lowest one and fourth quartile representing the highest one ( 
Q1- 0.46 to <1.28; Q2-1.28 to < 1.81; Q3- 1.81 to < 2.58; Q4- > 2.58 mU/l). There was no 
major statistically significant difference in age, weight, BMI, DBP, HbA1c, creatinine, eGFR, 
FT4 and lipid profile with the increment in TSH but a difference in trend was noted with risk 
factors including sex, SBP and prevalence of Type 2 diabetes across different groups (all P 
for trend < 0.05). In comparison to the patients in the lowest quartile of TSH, those in the 
second, third and highest quartiles had higher levels of UACR [1.6 (0.9-3.2); 1.7 (1.0-4.3); 
2.1 (0.8-4.4) and 2.4 (0.9-8.5) mg/mmol/ respectively], and this was statistically significant 
(P for trend= 0.02).   
2. Prevalence of microalbuminuria in different TSH levels       
The prevalence of microalbuminuria was different in the TSH quartiles. From the lowest 
quartile of TSH across to the highest one, the prevalence of microalbuminuria increased from 
26.9 % to 34.6%, 38.5% and 44.9% respectively (P for trend = 0.02, Figure 1). In comparison 
to the highest TSH quartile, the third, second and lowest TSH quartiles showed a significant 
decrease in the prevalence of microalbuminuria (p=0.04, 0.005 and 0.01 respectively).    
3. Association between TSH and Microalbuminuria  
In the univariable logistic regression model, the risk of microalbuminuria increased across 
TSH quartiles. The odds ratio (OR) for the highest TSH quartile compared with the lowest 
quartile was 1.98 [95% CI (1.12-3.49); p=0.01] and those in the second and third quartile 
were also more likely to have microalbuminuria [OR-1.48, 95% CI (0.83-2.65); p=0.17] and 
[OR-1.58, 95% CI (0.89-2.80); p=0.11] and the test for the trend was significant (P for trend 
= 0.02). We used two different models to adjust for potential confounding factors. In Model 2 
(Table 3) we adjusted for age, sex, BMI and type of diabetes and a logistic regression 
analysis showed similar association that the patients in the second, third and highest quartiles 
were more likely to have microalbuminuria compared to those in the lowest quartile [adjusted 
OR 1.45, 95% CI (0.8-2.63); p=0.21], [adjusted OR 1.56, 95%CI (0.86-2.81); p=0.13] and 
[adjusted OR 1.95, 95% CI (1.09-3.48); p=0.02] respectively with a statistically significant p 
for trend = 0.03. In Model 3 we adjusted for age, sex, BMI, type of diabetes, SBP, FT4 and 
high lipids and the association remained fairly similar. In such a adjusted models patients 
again were more likely to develop microalbuminuria when their TSH was in the highest 
quartile in comparison to the lowest quartile [adjusted OR 2.06, 95% CI (1.14-3.72); p=0.01] 
and the trend was identical in the second [adjusted OR 1.67, 95% CI (0.91-3.07); p=0.09] and 
in the third quartile [adjusted OR 1.67, 95% CI (0.92-3.05); p=0.09] and the test for trend was 
statistically significant (Ptrend  = 0.02).  We also performed a simple and multivariate adjusted 
linear regression analyses and we found TSH levels positively and significantly associated 
with UACR (p < 0.05) .     
We also performed stratified analyses for multivariate adjusted odd’s ratio of 
microalbuminuria with each 1 SD increment in log TSH concentration in different subgroups 
(Table 4) and we found that the associations between microalbuminuria and TSH were not 
consistent. We observed positive and significant association between TSH and 
microalbuminuria in the following subgroups of different strata: female population, age < 65 
years, BMI ≥ 25 kg/m
2
, patients with hypertension, type 2 diabetes and patients with 
hyperlipidemia. We didn’t observe any significant association in the remaining subgroups of 
different strata. The interactions between TSH and the risk factors was only significant in the 
age category (p=0.02) (Table 4).   
 
 
 
 
 
 
Discussion  
In the present study we demonstrated a statistically significant association between serum 
TSH and urine albumin excretion in euthyroid patients with diabetes and our results indicated 
that the prevalence of microalbuminuria increased gradually as the quartiles of TSH levels 
increased. Our results also indicated that TSH levels significantly correlated with UACR after 
adjustment for a wide spectrum of demographic and biochemical risk factors. We also 
observed that in our diabetic cohort the risk of microalbuminuria was higher with incremental 
rise in TSH when patients are younger (<65 years) and have raised BMI, hypertension and 
dyslipidemia and have type 2 diabetes.    
Microalbuminuria is a well recognised complication in patients with diabetes and serves as a 
marker of systemic endothelial dysfunction. 
15,16
 In addition it is also a well known predictor 
of diabetic nephropathy and an independent risk factor for cardiovascular disease (CVD), 
morbidity and mortality. 
17
 Thyroid hormones play an important role in the growth, 
development and physiology of the kidneys. Alteration in thyroid function causes remarkable 
changes in renal blood flow, glomeular filtration rate, tubular secretory and absorptive 
capacity, electrolyte pumps and structure of glomerular barrier 
13
 which may significantly 
influence renal handling of albumin and other related proteins. Several authors have studied 
the intricate relationship between serum TSH levels and intrarenal haemodynamic parameters 
in normoglycaemic euthyroid subjects and have demonstrated that TSH is an independent 
factor for determining renal function and chronic kidney disease. 
5,13
 Likewise, authors have 
also reported an independent association between FT3 concentration and microalbuminuria in 
large non diabetic population but no causal relationship was established. 
9
   
Our study provides a unique opportunity in studying the effects of serum TSH on urine 
albumin excretion in patients who had their thyroid function in the euthyroid range as 
previous studies examined a similar relationship in patients with diabetes but with established 
subclinical hypothyroidism (SCH). 
12,18,19
 Thyroid hormones elicit crucial effects vascular 
and endothelial functions. Patients with SCH have endothelial dysfunction characterized by 
reduced endothelium dependent vasodilatation and impaired nitric oxide (NO) availability 
which is partially independent of dyslipidemia and can be reversed through levothyroxine 
replacement. 
20
 A similar impaired vascular function will be expected in patients with mild 
SCH or in patients with TSH in the higher end of the reference range like our patients due to 
underlying arterial stiffness and increased systemic vascular resistance. This has been 
reported by Volzke et al 
21
 who found that serum TSH levels in the upper reference range are 
also associated with impaired endothelial function measured through flow mediated dilation.  
As endothelial dysfunction is associated with albuminuria in diabetes 
22
; therefore it is 
entirely possible that such dysfunction is the possible link between higher level of TSH and 
albuminuria.    
Thyroid function has a substantial impact on glucose and lipid metabolism and have been 
linked to components of insulin resistance (fasting insulin and HOMA-IR). 
23
 On the other 
hand, insulin resistance has been described to be the principal pathophysiological process that 
underpins metabolic syndrome (Mets) 
24
 which is a cluster of modifiable risk factors 
associated with increased risk developing CVD. The NHANES III data have shown strong 
positive association between microalbuminuria and Mets 
25
 and other studies have also shown 
that the underlying insulin resistance would be a major determinant of microalbuminuria. 
26
 
Previous studies have identified links between components of Mets with low normal thyroid 
function (euthyroid state) 
23
 and in patients with subclinical thyroid disease. 
27
 Such findings 
are consistent with our observations that elevated TSH (in euthyroid range) can increase the 
risk of microalbuminuria in patients when patients have components of Mets like insulin 
resistance (manifested as type 2 diabetes), raised BMI, hypertension and dyslipidemia. We 
also showed that the risk is higher if patients younger (<65 years) and if are females.  
Our study has limitations. First it has a cross sectional design which doesn’t establish the 
casual relationship between TSH and microalbuminuria hence prospective, longitudinal 
studies are needed to clarify this intricate relationship. Second, we didn’t have information 
about smoking status of individual patients which may impact thyroid function, kidney 
function and urine albumin excretion and may eb a key confounder. Third, we didn’t include 
thyroid auto-antibody status in our assessment as anti thyroperoxidase (TPO) antibody might 
be responsible for endothelial dysfunction and subsequent microalbuminuria in euthyroid 
patients with Hashimoto’s disease as reported by other authors. 
28
   
Conclusion  
In summary, our study shows a significant association and positive correlation between 
microalbuminuria, a surrogate marker or endothelial dysfunction and serum TSH in a 
euthyroid diabetic population. It helps us to understand the influence of thyroid function in 
the development of microalbuminuria and we suggest that gradually rising TSH, even though 
in the euthyroid range should be considered as an additional risk factor for microalbuminuria 
beyond the traditional risk factors in diabetic subjects.  Further studies are needed to explore 
this relationship and for development of intervention strategies.  
 
 
 
